Does baseline carotid intima–media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima–media thickness progression? The METEOR study

作者
John R. Crouse,Michiel L. Bots,Gregory W. Evans,M K Palmer,Daniel H. O’Leary,Diederick E. Grobbee,Joel S. Raichlen
出处
期刊:European journal of cardiovascular prevention & rehabilitation [SAGE Publishing]
卷期号:17 (2): 223-229 被引量:10
标识
DOI:10.1097/hjr.0b013e3283359c38
摘要

BACKGROUND: Many studies have used carotid intima-media thickness (CIMT) measurement to study atherosclerosis and the efficacy of interventions. The placebo-controlled Measuring Effects on intima-media Thickness: an Evaluation Of Rosuvastatin (METEOR) study showed significant reduction in the progression rate of maximum CIMT with 2 years of lipid treatment in asymptomatic individuals with subclinical atherosclerosis. DESIGN: The present post-hoc subgroup analysis of METEOR was carried out to determine whether the effect of rosuvastatin treatment varied according to baseline CIMT level. METHODS: To assess the relationship between efficacy of treatment with rosuvastatin versus placebo and baseline CIMT, we analyzed the effects on the primary CIMT endpoint in participants stratified by baseline quartiles of CIMT (Q1-Q4) using all individuals with a baseline reading and at least one post-baseline CIMT reading. Statistical analysis was carried out using a multilevel repeated-measures linear mixed effects model. RESULTS: In total, 876 participants were included in the analysis. In all quartiles, progression of mean maximum CIMT was significantly slower in rosuvastatin-treated individuals as compared with placebo controls. Although the magnitude of the treatment effect appeared larger in those with the highest baseline CIMT, statistical testing indicated that the magnitude of the treatment effect did not vary significantly with levels of baseline CIMT. CONCLUSION: This subgroup analysis of the METEOR study showed that in middle-aged adults with sub-clinical atherosclerosis, rosuvastatin treatment resulted in significant reduction in mean maximum CIMT progression in four quartiles of baseline CIMT, with no evidence for difference in benefit across levels of baseline CIMT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小巧的小蚂蚁完成签到 ,获得积分10
刚刚
SmileLin发布了新的文献求助10
刚刚
小甜完成签到,获得积分10
1秒前
木心宇完成签到,获得积分10
1秒前
11完成签到,获得积分10
2秒前
鲸落发布了新的文献求助30
2秒前
张钰琪完成签到,获得积分10
2秒前
花阳完成签到 ,获得积分10
2秒前
伟大毕业旅程完成签到 ,获得积分10
2秒前
滑动变阻器完成签到,获得积分10
3秒前
莓烦恼完成签到 ,获得积分10
3秒前
秋风的应助被NiaoJiang采纳,获得10
3秒前
jun完成签到,获得积分10
4秒前
冀晓梦完成签到,获得积分10
4秒前
小孟小孟完成签到 ,获得积分10
4秒前
4秒前
hhhhhg完成签到,获得积分10
5秒前
1b完成签到,获得积分10
5秒前
nonory完成签到,获得积分10
6秒前
阿飞完成签到,获得积分10
6秒前
乐观青完成签到,获得积分10
6秒前
6秒前
motujun发布了新的文献求助10
6秒前
tkai关注了科研通微信公众号
7秒前
Ftplanet完成签到,获得积分10
7秒前
binges on choco完成签到,获得积分10
8秒前
阔达采白完成签到,获得积分10
8秒前
体贴洋葱完成签到 ,获得积分10
8秒前
正经大善人完成签到,获得积分10
8秒前
向雅完成签到,获得积分0
9秒前
heluoyu完成签到,获得积分10
10秒前
TIZI完成签到,获得积分10
10秒前
李琪完成签到 ,获得积分10
10秒前
贪玩的芯完成签到,获得积分10
10秒前
田様的应助被123采纳,获得10
10秒前
赵亚南完成签到,获得积分10
10秒前
寂寞的面包完成签到 ,获得积分10
11秒前
飘逸山兰完成签到,获得积分10
11秒前
吴锋发布了新的文献求助10
11秒前
懵懂的弱完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039